Keel Point’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$601K Sell
1,270
-327
-20% -$165K 0.04% 241
2025
Q4
$746K Sell
1,597
-161
-9% -$74.8K 0.04% 226
2025
Q3
$749K Buy
1,758
+13
+0.7% +$5.04K 0.05% 225
2025
Q2
$669K Buy
1,745
+174
+11% +$62.7K 0.04% 240
2025
Q1
$543K Buy
1,571
+104
+7% +$33.4K 0.04% 237
2024
Q4
$440K Sell
1,467
-354
-19% -$124K 0.04% 259
2024
Q3
$740K Buy
1,821
+273
+18% +$100K 0.06% 180
2024
Q2
$571K Buy
1,548
+63
+4% +$20.5K 0.05% 207
2024
Q1
$495K Buy
1,485
+5
+0.3% +$1.53K 0.05% 202
2023
Q4
$401K Sell
1,480
-4
-0.3% -$989 0.05% 220
2023
Q3
$365K Sell
1,484
-52
-3% -$14.2K 0.05% 205
2023
Q2
$466K Buy
1,536
+102
+7% +$28.4K 0.06% 171
2023
Q1
$378K Buy
1,434
+4
+0.3% +$1.02K 0.05% 195
2022
Q4
$343K Buy
+1,430
New +$320K 0.05% 199

Other funds holding HCA

Keel Point's HCA Position: Q1 2026 in Review

Keel Point reduced its HCA Healthcare (HCA) stake by 20% in Q1 2026, selling an estimated $165K and leaving 1,270 shares worth $601K. The position accounts for 0.04% of the portfolio, ranked #241.

Keel Point first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. The position peaked at $749K in Q3 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Keel Point held 1,270 shares of HCA Healthcare worth $601K as of Q1 2026.
  • Keel Point sold 327 HCA Healthcare shares in Q1 2026, an estimated $165K.
  • HCA Healthcare made up 0.04% of Keel Point's portfolio in Q1 2026, its #241 holding.
  • Keel Point first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • Keel Point's HCA Healthcare position peaked at $749K in Q3 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.